The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-3-((2S,3S)-3-hydroxy-2-methyl-4-methylenedecanoyl)-4-isopropyloxazolidin-2-one ID: ALA3765653
PubChem CID: 49846978
Max Phase: Preclinical
Molecular Formula: C18H31NO4
Molecular Weight: 325.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C=C(CCCCCC)[C@@H](O)[C@H](C)C(=O)N1C(=O)OC[C@@H]1C(C)C
Standard InChI: InChI=1S/C18H31NO4/c1-6-7-8-9-10-13(4)16(20)14(5)17(21)19-15(12(2)3)11-23-18(19)22/h12,14-16,20H,4,6-11H2,1-3,5H3/t14-,15+,16+/m0/s1
Standard InChI Key: CUDWZXIFWQVCFD-ARFHVFGLSA-N
Molfile:
RDKit 2D
23 23 0 0 0 0 0 0 0 0999 V2000
0.7500 -1.0323 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2135 0.3943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.2760 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2135 0.3943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7500 -1.0323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3548 0.7651 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.6375 0.8602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8853 2.0344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5307 0.0588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0031 2.7742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3040 3.5228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3071 5.0236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6079 5.7721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6461 5.1703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0350 3.3761 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 7.2729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3421 2.9209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2689 5.6254 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.9119 8.0215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9150 9.5223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2158 10.2708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2190 11.7716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2591 12.3701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
1 5 1 0
2 6 2 0
7 8 1 0
7 9 1 0
4 7 1 6
10 11 1 0
11 12 1 0
12 13 1 0
13 14 2 0
10 15 2 0
13 16 1 0
11 17 1 1
12 18 1 1
3 10 1 0
16 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 325.45Molecular Weight (Monoisotopic): 325.2253AlogP: 3.51#Rotatable Bonds: 9Polar Surface Area: 66.84Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.15CX LogD: 4.15Aromatic Rings: ┄Heavy Atoms: 23QED Weighted: 0.52Np Likeness Score: 0.95
References 1. Singh S, Gajulapati V, Gajulapati K, Goo JI, Park YH, Jung HY, Lee SY, Choi JH, Kim YK, Lee K, Heo TH, Choi Y.. (2016) Structure-activity relationship study of a series of novel oxazolidinone derivatives as IL-6 signaling blockers., 26 (4): [PMID:26810262 ] [10.1016/j.bmcl.2016.01.016 ]